Neurology ReviewsAround 5% of US Population Diagnosed With Autoimmune DiseaseJanuary 14, 2025Rare DiseasesMultiple SclerosisMyasthenia Gravis
Neurology ReviewsMyasthenia Gravis: Where Does Traditional Therapy Fit In?November 6, 2024Myasthenia GravisRare DiseasesNeuromuscular Disorders
Neurology ReviewsNeurologists Lack Awareness of Steroid ToxicityOctober 28, 2024Neuromuscular DisordersMyasthenia GravisRare Diseases
Neurology ReviewsDigital Tool May Help Neurologists Assess Steroid ToxicityOctober 28, 2024Myasthenia GravisNeuromuscular DisordersRare Diseases
Neurology ReviewsPediatric Myasthenia Gravis: Don’t Treat Children Like AdultsOctober 22, 2024Myasthenia GravisNeuromuscular DisordersPediatricsRare Diseases
Neurology ReviewsMyasthenia Gravis: Similar Symptoms in Relatives Raise Question of GenesOctober 18, 2024Myasthenia GravisNeuromuscular DisordersRare Diseases
Neurology ReviewsSustained Control with Investigational Monoclonal Antibody for Myasthenia GravisOctober 17, 2024Myasthenia GravisNeuromuscular DisordersRare Diseases
Neurology ReviewsFirst-in-Class B-Cell Depleting Agent Promising for Myasthenia GravisOctober 17, 2024Myasthenia GravisNeuromuscular DisordersRare Diseases
Neurology ReviewsMyasthenia Gravis: Patient Choice, Cultural ChangeSeptember 30, 2024Rare DiseasesMyasthenia GravisNeuromuscular Disorders
Don't Miss the Dx: A 63-Year-Old Man With Proptosis, Diplopia, and Upper-Body WeaknessMarch 21, 2024Myasthenia Gravis
Myasthenia Gravis: Reflections on Past Challenges and Evolving StrategiesFebruary 28, 2024Myasthenia Gravis
